Dr. Rupert Bauersachs and Dr. C. Michael Gibson Discuss: Reductions In Total Ischemic Events With Rivaroxaban In Patients With Symptomatic Pad After Revascularization: The VOYAGER PAD Trial May 15, 2021 2021 | ACC | Cardiology | Slides | Trial | Video Tags: 2021, ACC, Cardiology, slides, video Loading… Taking too long? Reload document | Open in new tab Download Disclosures: TBD Article Navigation Dr. Carolyn Lam and Dr. C. Michael Gibson Discuss How to Initiate Heart Failure Drugs Dr. Eugene Braunwald and Dr. C. Michael Gibson Discuss: Prospective Arni Versus Ace Inhibitor Trial To Determine Superiority In Reducing Heart Failure Events After Myocardial Infarction (paradise-mi)
Reload document 
Open in new tab